Madison Asset Management LLC Reduces Holdings in Agilent Technologies, Inc. $A

Madison Asset Management LLC lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 6.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 609,418 shares of the medical research company’s stock after selling 44,401 shares during the quarter. Madison Asset Management LLC’s holdings in Agilent Technologies were worth $82,924,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the company. World Investment Advisors raised its holdings in Agilent Technologies by 4.6% during the fourth quarter. World Investment Advisors now owns 5,813 shares of the medical research company’s stock valued at $767,000 after acquiring an additional 258 shares during the period. Bailard Inc. boosted its holdings in shares of Agilent Technologies by 35.4% during the 4th quarter. Bailard Inc. now owns 2,633 shares of the medical research company’s stock valued at $358,000 after purchasing an additional 689 shares during the last quarter. Swiss Life Asset Management Ltd grew its position in shares of Agilent Technologies by 9.8% during the fourth quarter. Swiss Life Asset Management Ltd now owns 75,433 shares of the medical research company’s stock valued at $10,264,000 after purchasing an additional 6,730 shares in the last quarter. NewEdge Wealth LLC grew its holdings in Agilent Technologies by 74.1% during the 4th quarter. NewEdge Wealth LLC now owns 6,183 shares of the medical research company’s stock valued at $841,000 after buying an additional 2,632 shares in the last quarter. Finally, RB Capital Management LLC bought a new position in shares of Agilent Technologies during the 4th quarter valued at approximately $206,000.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Morgan Stanley reduced their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. TD Cowen reduced their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective on the stock. Finally, Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Trading Up 1.3%

NYSE:A opened at $112.93 on Wednesday. The stock has a market capitalization of $31.91 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 2.35 and a beta of 1.22. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The firm has a 50 day moving average of $115.46 and a 200 day moving average of $131.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.